Enzymit
Latest round
- Series A
Last raised
- Sep 2024
Total raised
- $15M
Investors
- 5
About Enzymit
, is a platform that uses computational design tools to create novel bio enzymes and biomolecular components in a cost-effective manner. In April 2022, Enzymit Ltd. The firm uses data gathered from protein sequence changes and applies deep learning algorithms to create a new chemistry enzyme design pipeline. The company develops enzymes that meet human needs, catalyze new reactions, and exceed existing enzymes without the use of toxic cell-manufacturing processes. Enzymit develops novel enzymatic processes that convert carbon from the atmosphere into new biopolymers that do not occur naturally in Nature at a lower cost and in a more environmentally friendly manner. The company intends to use the April 2022 funds to accelerate the development of its computational design platform and expand its product pipeline.
Who invested in Enzymit
5 investors across 2 rounds
See all investors in Enzymit
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Enzymit
Who invested in Enzymit?
Enzymit has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enzymit raised?
Enzymit has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Enzymit last raise money?
Enzymit's most recent round on record is a Series A, in Sep 2024.
What does Enzymit do?
, is a platform that uses computational design tools to create novel bio enzymes and biomolecular components in a cost-effective manner.
Where is Enzymit headquartered?
Enzymit is headquartered in Ness Ziona, Israel.
Which VCs invest in companies like Enzymit?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Enzymit's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Enzymit? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.